We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
It's illegal to drive if you're unfit to do so because you're on legal or illegal drugs, or you have certain levels of drugs or medicine in your blood
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Report of the review of the evidence for dependence on, and withdrawal from, prescribed medicines.
Directions given by the Secretary of State for Health under powers conferred by statute.
Upper Tribunal Administrative Appeals Chamber decision by Judge on 2024.
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
Prescription Cost Analysis (PCA) provides details of the number of items and the net ingredient cost of all prescriptions dispensed in Northern Ireland. The drugs dispensed are listed by British National Formulary (BNF) therapeutic class.
Advice for healthcare professionals on the reclassification of codeine linctus to a prescription-only medicine (POM), following a public consultation.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
An investigation by the Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) has led to charges being brought against five people from the Wolverhampton area for the illegal supply of prescription-only medicines and controlled drugs.
Prescription charges review: implementing exemption from prescription charges for people with long term conditions.
A series of indicators to inform safer prescribing practice to help pharmacists, clinicians and patients review prescribed medication and prevent harm.
Plans to make better use of pharmacies, improve access to primary care and maximise the contribution of pharmacy professionals set out in new consultation.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.